Trial Details

Not Recruiting
Basic Information
Clinical ID c5018
Identifier ISRCTN13495664
Trial Title SARS-CoV2 Vaccination immunogenicity in Immunosuppressed inflammatory bowel disease Patients
Trial URL Visit Original Page
Study Information
Study Results

Yes
Conditions Immune responses to SARS-CoV-2 vaccination in immunosuppressed inflammatory bowel disease patients. Not Applicable
Interventions 600 IBD patients will be recruited stratified according to the immunosuppressive medication they are on. Patients must have been for at least 3 months on the following treatments: thiopurines (n=100), infliximab (anti-TNF) (n=100), combination infliximab/
Participant Information
Sponsor Imperial College London
City NULL
Country/Region United Kingdom
Enrollment Criteria
Sex Requirement ALL
Age Requirement NULL
Study Design
Study Type Observational
Phase NULL
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL